Common questions about Kliovance (FAQ)
Q: What are the most common reasons doctors prescribe Kliovance?
A: According to official product information, Kliovance is primarily indicated to help relieve common symptoms occurring after menopause, such as hot flushes and night sweats. It is also approved for the prevention of osteoporosis (bone thinning) in postmenopausal women when other treatments are not considered suitable.
Q: Does Kliovance help with hot flashes?
A: Yes, official regulatory documents state that Kliovance is indicated for the alleviation of menopausal symptoms, which includes hot flushes (sudden feelings of heat to the face, neck, and chest).
Q: Can Kliovance improve mood swings during menopause?
A: While the primary indication is for physical symptoms, some patient information suggests that as menopausal symptoms are relieved, mood changes may also be improved. However, official labeling notes that anxiety is an uncommon side effect and depression is a common side effect of this treatment.
Q: How long does it typically take for Kliovance to start working?
A: The exact onset is not detailed in core regulatory documents, but clinical experience suggests that relief from menopausal symptoms may begin to be noticeable within just a few weeks of starting the treatment.
Q: Does Kliovance affect my cholesterol levels?
A: Official warnings and precautions note that the use of Hormone Replacement Therapy (HRT) may result in an increase in the circulating levels of triglycerides in the blood. If a patient has high levels of fat in their blood (triglycerides), healthcare professionals typically monitor these levels closely during treatment.
Q: Will Kliovance help with night sweats?
A: Yes, official product information indicates that Kliovance is used to alleviate menopausal symptoms, and this includes night sweats.
Q: How quickly do side effects from Kliovance usually go away?
A: Common effects such as breast pain or tenderness are generally expected to improve after the first four to six weeks. Irregular bleeding or spotting, a very common side effect, is expected to decrease over the first three to six months of continuous use.
Q: What are some less common but possible side effects of Kliovance?
A: Regulatory documents classify some effects as Uncommon (occurring in fewer than 1 in 100 people). These may include hair loss, bloating, acne, leg cramps, and skin reactions such as hives or itching.
Q: Is Kliovance recommended for perimenopausal women?
A: Kliovance is intended for use in postmenopausal women, meaning those who are typically at least 12 months past their last natural period. The labeling for Kliovance is specific to this group, and other forms of HRT are typically considered for women who are still in the perimenopausal phase.
Q: Why do some people feel more anxious after starting Kliovance?
A: The regulatory documents list anxiety as an uncommon side effect of the tablets. This means that a small number of people taking Kliovance may experience increased feelings of anxiety.
Q: Can Kliovance affect fertility?
A: This medication is only indicated for use in postmenopausal women. It is contraindicated during pregnancy because it is not intended for the population of reproductive potential.
Q: How does Kliovance affect breast tenderness?
A: Breast pain or tenderness is officially documented as a Very Common side effect, meaning it may affect more than 1 in 10 people taking the medication. This effect is generally expected to decrease over the first few weeks of treatment.
Q: Is Kliovance considered a 'bioidentical' hormone product?
A: The official product information notes that the estradiol component is chemically identical to human estrogen. However, the norethisterone acetate (progestagen) is a synthetic derivative. The official term 'bioidentical' is not used in regulatory labeling to classify this combined product.
Q: Does Kliovance interact with common anti-depressants?
A: The hormones are broken down by an enzyme called CYP3A4, and some anti-depressants may affect this enzyme, which can potentially influence hormone levels. The prescribing information should be consulted for details regarding specific drug interactions.
Q: Does Kliovance interact with grapefruit juice?
A: Grapefruit and grapefruit juice are known to be strong inhibitors of the CYP3A4 enzyme, which is involved in breaking down the hormone components. This could potentially increase the blood concentration of the hormones in the body.
Q: Will Kliovance stop periods completely?
A: Kliovance is a continuous combined regimen, which means both hormones are taken daily without a break. The continuous combined design is intended to minimize the monthly withdrawal bleeding that is associated with sequential HRT types.
Q: Can drinking alcohol affect how Kliovance works?
A: While not listed as a direct interaction in the core product information, public health information suggests that alcohol consumption may increase estrogen levels in the body, which could potentially impact the overall risk profile of HRT.
Q: Is it normal to have some spotting when first starting Kliovance?
A: Yes, irregular bleeding or spotting (Vaginal haemorrhage) is listed as a Very Common effect. This effect is noted to typically occur during the first three to six months of use and generally decreases over time.
Q: Is weight gain a common side effect of Kliovance?
A: Yes, Weight increased is officially classified in regulatory documents as a Common side effect, meaning it may affect between 1 in 100 and 1 in 10 people.
Q: Can Kliovance cause headaches or migraines?
A: Headache is officially classified as a Common side effect of the medication. Migraines are not specifically mentioned in the common side effects list.
Q: Can Kliovance be taken with thyroid medication?
A: The estrogen component can affect the levels of certain proteins that carry thyroid hormones in the blood. This could potentially lead to a lower level of free thyroid hormone, which may necessitate an adjustment of the thyroid medication dose.
